Patrick Janku

Single oral administration of dronabinol increases ocular blood flow in patients with glaucoma.

This pilot study demonstrates that systemic dronabinol enhances ONHBF in glaucoma patients, suggesting its potential as adjunct therapy for glaucoma by targeting vascular dysfunction.